Swedbank’s Royalty Pharma RPRX Stock Holding History

Swedbank’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$601M	Sell	10,726,608 -860,085	-7%	-$44.8M	0.52%	42
2026 Q1	$556M	Sell	11,586,693 -355,450	-3%	-$15.6M	0.58%	36
2025 Q4	$461M	Sell	11,942,143 -258,127	-2%	-$9.84M	0.45%	48
2025 Q3	$430M	Buy	12,200,270 +42,800	+0.4%	+$1.55M	0.44%	51
2025 Q2	$438M	Hold	12,157,470	–	–	0.49%	39
2025 Q1	$378M	Sell	12,157,470 -6,700	-0.1%	-$212K	0.5%	44
2024 Q4	$310M	Buy	12,164,170 +1,136,800	+10%	+$30.1M	0.38%	57
2024 Q3	$312M	Buy	11,027,370 +213,900	+2%	+$5.92M	0.4%	55
2024 Q2	$285M	Buy	+10,813,470	New	+$300M	0.38%	56
2024 Q1	–	Sell	-5,468,900	Closed	-$154M	–	689
2023 Q4	$154M	Buy	5,468,900 +1,517,000	+38%	+$41.7M	0.25%	82
2023 Q3	$107M	Buy	3,951,900 +101,800	+3%	+$3.02M	0.19%	104
2023 Q2	$118M	Buy	3,850,100 +795,155	+26%	+$26.9M	0.2%	103
2023 Q1	$110M	Buy	3,054,945 +1,215,528	+66%	+$45.1M	0.22%	99
2022 Q4	$72.7M	Buy	1,839,417 +448,500	+32%	+$18.7M	0.16%	132
2022 Q3	$55.9M	Buy	1,390,917 +897,400	+182%	+$38.3M	0.13%	146
2022 Q2	$20.7M	Hold	493,517	–	–	0.05%	289
2022 Q1	$19.2M	Hold	493,517	–	–	0.04%	338
2021 Q4	$19.8M	Hold	493,517	–	–	0.03%	350
2021 Q3	$17.8M	Buy	493,517 +166,017	+51%	+$6.45M	0.03%	370
2021 Q2	$13.4M	Buy	+327,500	New	+$13.9M	0.03%	422

Other funds holding RPRX

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

KMC

Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return

FIC

FCG Investment Company Germantown, Tennessee $289M AUM

Swedbank's RPRX Position: Q2 2026 in Review

Swedbank reduced its Royalty Pharma (RPRX) stake by 7.4% in Q2 2026, selling an estimated $44.8M and leaving 10,726,608 shares worth $601M. The position accounts for 0.52% of the portfolio, ranked #42.

Swedbank first reported a position in RPRX in Q2 2021 and has held it in 20 quarters since. 54 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Swedbank held 10,726,608 shares of Royalty Pharma worth $601M as of Q2 2026.
Swedbank sold 860,085 Royalty Pharma shares in Q2 2026, an estimated $44.8M.
Royalty Pharma made up 0.52% of Swedbank's portfolio in Q2 2026, its #42 holding.
Swedbank first reported a position in Royalty Pharma in Q2 2021 and has held it in 20 quarters since.
54 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.